1. Home
  2. TBLA vs IOVA Comparison

TBLA vs IOVA Comparison

Compare TBLA & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBLA
  • IOVA
  • Stock Information
  • Founded
  • TBLA 2007
  • IOVA 2007
  • Country
  • TBLA United States
  • IOVA United States
  • Employees
  • TBLA N/A
  • IOVA N/A
  • Industry
  • TBLA Computer Software: Programming Data Processing
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TBLA Technology
  • IOVA Health Care
  • Exchange
  • TBLA Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • TBLA 976.2M
  • IOVA 975.1M
  • IPO Year
  • TBLA N/A
  • IOVA N/A
  • Fundamental
  • Price
  • TBLA $3.20
  • IOVA $2.20
  • Analyst Decision
  • TBLA Strong Buy
  • IOVA Buy
  • Analyst Count
  • TBLA 5
  • IOVA 11
  • Target Price
  • TBLA $4.50
  • IOVA $11.90
  • AVG Volume (30 Days)
  • TBLA 1.2M
  • IOVA 10.2M
  • Earning Date
  • TBLA 11-06-2025
  • IOVA 11-06-2025
  • Dividend Yield
  • TBLA N/A
  • IOVA N/A
  • EPS Growth
  • TBLA N/A
  • IOVA N/A
  • EPS
  • TBLA 0.04
  • IOVA N/A
  • Revenue
  • TBLA $1,817,019,000.00
  • IOVA $241,525,000.00
  • Revenue This Year
  • TBLA $8.37
  • IOVA $68.14
  • Revenue Next Year
  • TBLA $4.65
  • IOVA $56.64
  • P/E Ratio
  • TBLA $78.41
  • IOVA N/A
  • Revenue Growth
  • TBLA 12.01
  • IOVA 636.99
  • 52 Week Low
  • TBLA $2.50
  • IOVA $1.64
  • 52 Week High
  • TBLA $4.30
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • TBLA 33.27
  • IOVA 47.74
  • Support Level
  • TBLA $3.18
  • IOVA $2.09
  • Resistance Level
  • TBLA $3.60
  • IOVA $2.34
  • Average True Range (ATR)
  • TBLA 0.08
  • IOVA 0.12
  • MACD
  • TBLA -0.04
  • IOVA 0.02
  • Stochastic Oscillator
  • TBLA 4.76
  • IOVA 54.88

About TBLA Taboola.com Ltd.

Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, United States, Germany, Rest of the world. It generates the majority of its revenue from the United States.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: